Aedis Energy Inc Class A (ADIS) Risk Analysis

Our Certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a breach of fiduciary duty, any action asserting a claim against us arising pursuant to the DGCL, our certificate of incorporation or our bylaws or any action asserting a claim against us that is governed by the internal affairs doctrine. These choice of forum provisions may limit a stockholder's ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees and may discourage these types of lawsuits. This provision would not apply to claims brought to enforce a duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. Our certificate of incorporation provides further that, to the fullest extent permitted by law, the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. However, Section 22 of the Securities Act provides that federal and state courts have concurrent jurisdiction over lawsuits brought under the Securities Act or the rules and regulations thereunder. To the extent the exclusive forum provision restricts the courts in which claims arising under the Securities Act may be brought, there is uncertainty as to whether a court would enforce such a provision. We note that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. Furthermore, the enforceability of similar choice of forum provisions in other companies' certificates of incorporation has been challenged in legal proceedings and it is possible that a court could find these types of provisions to be inapplicable or unenforceable. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions and there can be no assurance that such provisions will be enforced by a court in those other jurisdictions. If a court were to find the exclusive-forum provision contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm its business.

Our certificate of incorporation and bylaws contain provisions that could depress the trading price of the common stock by acting to discourage, delay, or prevent a change of control of us or changes in our management that our stockholders may deem advantageous. These provisions include, without limitation, the following: - a classified board of directors so that not all members of our Board are elected at one time;- the right of the board of directors to establish the number of directors and fill any vacancies and newly created directorships;- director removal by stockholders solely for cause and with the affirmative vote of at least two-thirds (2/3) of the voting power of our then-outstanding shares of capital stock entitled to vote generally in the election of directors;- "blank check" preferred stock that our Board could use to implement a stockholder rights plan;- the right of our Board to issue our authorized but unissued common stock and preferred stock without stockholder approval;- no ability of our stockholders to call special meetings of stockholders;- no right of our stockholders to act by written consent, which requires all stockholder actions to be taken at a meeting of our stockholders;- limitations on the liability of and the provision of indemnification to, our director and officers;- the right of the board of directors to make, alter, or repeal our Bylaws; and - advance notice requirements for nominations for election to our Board or for proposing matters that can be acted upon by stockholders at annual stockholder meetings. Any provision of our certificate of incorporation or our bylaws that has the effect of delaying or deterring a change in control could limit the opportunity for our stockholders to receive a premium for their shares of common stock and could also affect the price that some investors are willing to pay for common stock.

We have warrants outstanding to purchase up to 4,135,910 shares of our common stock. We will also have the ability to initially issue up to 11,200 shares of our common stock under the 2023 Plan (as defined below). We may issue additional shares of common stock or other equity securities of equal or senior rank in the future in connection with, among other things, future acquisitions or repayment of outstanding indebtedness, without stockholder approval, in a number of circumstances. Our issuance of additional shares of common stock or other equity securities of equal or senior rank could, without limitation, have the following effects: - our existing stockholders' proportionate ownership interest in us will decrease;- the amount of cash available per share, including for payment of dividends (if any) in the future, may decrease;- the relative voting strength of each previously outstanding share of common stock may be diminished; and - the market price of our shares of common stock may decline.

Our common stock is listed on OTC Market under the symbol "ALCE" and trades on that market. We cannot assure you that an active trading market for its common stock will be sustained. Accordingly, we cannot assure you of the liquidity of any trading market, your ability to sell your shares of common stock when desired or the prices that you may obtain for your shares. As a result of being listed on the OTC Market and no longer listed on a national exchange, we face significant material adverse consequences, including but not limited to: - a limited availability of market quotations for our securities;- reduced liquidity for our securities;- a limited amount of news and analyst coverage for the company; and - a decreased ability to issue additional securities or obtain additional financing in the future. The conversion of our outstanding Series B, Series C, Series D and Series E Convertible Preferred Stock into shares of common stock, and the down-round anti-dilution protections contained in the certificates of designation governing such preferred stock, could result in significant dilution to holders of our common stock and may adversely affect the market price of our common stock. As of the date of this Report, we have outstanding 21,150 shares of Series B Convertible Preferred Stock (the "Series B"), 6,015 shares of Series C Convertible Preferred Stock (the "Series C"), 9,733 shares of Series D Convertible Preferred Stock (the "Series D"), and 684 shares of Series E Convertible Preferred Stock (the "Series E"). Each series is convertible into shares of our common stock at the option of the holder, at a conversion price that is subject to downward adjustment upon certain dilutive issuances. Specifically, the certificates of designation governing the Series B, Series C, Series D and Series E each contain "down-round" or "full ratchet" anti-dilution provisions, pursuant to which the applicable conversion price is automatically reduced to the lowest price per share at which the Company issues common stock or convertible securities during specified adjustment periods. The Series B conversion price is subject to adjustment through December 31, 2026; the Series C conversion price is subject to adjustment through December 31, 2028; and the Series D and Series E conversion prices are each subject to adjustment for twelve months from their respective issuance dates. As a result of dilutive issuances that have occurred since the original issuance of each series, the effective conversion prices may have been, or may in the future be, reduced significantly below the original conversion prices set forth in the applicable certificates of designation. The face value of the outstanding convertible preferred stock is substantial. Each share of Series B has a face value of $1,000, with an original conversion price of $1.00 per share (subject to downward adjustment). Each share of Series C, Series D and Series E has a value of $1,000, with a conversion price of $0.10 per share (subject to downward adjustment). If all currently outstanding shares of convertible preferred stock were converted at their stated conversion prices (without giving effect to any further downward adjustments or beneficial ownership limitations), the holders would receive an aggregate number of shares of common stock that would substantially exceed the number of shares of common stock currently outstanding, resulting in massive dilution to existing common stockholders. Although the certificates of designation for each series contain beneficial ownership limitations (19.99% for Series B and Series C, 9.99% for Series D, and 4.99% for Series E) that restrict the number of shares any individual holder may acquire upon conversion at any one time, these limitations do not prevent dilution in the aggregate - they merely limit the pace at which any single holder may convert. Holders may convert in successive tranches over time up to the applicable limits, and multiple holders converting simultaneously could result in significant cumulative dilution. Furthermore, if the Company issues additional shares of common stock or convertible securities at prices below the then-effective conversion prices during the applicable adjustment periods, the conversion prices will be further reduced, resulting in even greater potential dilution upon conversion. The Company's ongoing need for capital and its history of issuing equity and convertible securities at declining prices increases the likelihood that additional dilutive issuances will occur, triggering further downward adjustments to the conversion prices. The potential for significant dilution from the conversion of outstanding preferred stock, and the ongoing risk of further downward price adjustments, may depress the market price of our common stock, make it more difficult for us to raise equity capital on favorable terms, discourage new investors from purchasing our common stock, and reduce the value of existing stockholders' investments. In addition, the overhang created by a large number of shares of common stock issuable upon conversion of preferred stock may create downward pressure on our stock price even if no conversions have yet occurred, as the market anticipates future dilution.

The price of our stock has experienced substantial price volatility and may continue to do so in the future. From January 1, 2025 to April 30, 2026, our stock price fluctuated between a low of $0.0006 per share and a high of $183.36 per share, which reflects a 1:200 reverse stock split. Additionally, the energy and technology industries, and the stock market as a whole have, from time to time, experienced extreme stock price and volume fluctuations that have affected stock prices in ways that may have been unrelated to the performance of the companies in these sectors. We believe the price of our stock should reflect expectations of future growth and profitability. If we fail to meet expectations related to future growth, profitability, or other market expectations, the price of our stock may decline significantly, which could have a material adverse impact on investor confidence and employee retention.

The market price of our common stock may fluctuate significantly in response to numerous factors and may continue to fluctuate for these and other reasons, many of which are beyond our control, including, but not limited to: - actual or anticipated fluctuations in our revenue and results of operations;- any financial projections we may provide to the public in the future, any changes in these projections or its failure to meet these projections;- failure of securities analysts to initiate and maintain our coverage, changes in financial estimates or ratings by any securities analysts who follow us or its failure to meet these estimates or the expectations of investors;- announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, results of operations or capital commitments;- changes in operating performance and stock market valuations of other clean energy and alternative energy companies generally, or those in the energy industry in particular;- price and volume fluctuations in the overall stock market, including as a result of trends in the economy as a whole;- trading volume of our common stock;- the inclusion, exclusion or removal of our common stock from any indices;- changes in our Board or management;- transactions in our securities by our directors, officers, affiliates and other major investors;- lawsuits threatened or filed against us;- changes in laws or regulations applicable to our business;- changes in our capital structure, such as future issuances of debt or equity securities;- short sales, hedging and other derivative transactions involving our capital stock;- general economic conditions in the United States and other markets in which we operate;- pandemics or other public health crises, including, but not limited to, the COVID-19 pandemic (including additional variants);- other events or factors, including those resulting from war, incidents of terrorism or responses to these events; and - the other factors described in this "Risk Factors" section. The stock market has recently experienced extreme price and volume fluctuations. The market prices of securities of companies have experienced fluctuations that often have been unrelated or disproportionate to their operating results. In the past, stockholders have sometimes instituted securities class action litigation against companies, and particularly against companies who have recently "gone public" through a DeSPAC transaction, following periods of volatility in the market price of their securities. Any similar litigation against us could result in substantial costs, divert management's attention and resources and harm its business, financial condition and results of operations.

We are an "emerging growth company" as defined in Section 2(a)(19) of the Securities Act, as modified by the JOBS Act. As such, we are eligible for and intends to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies for as long as it continues to be an emerging growth company, including, but not limited to, (a) not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, (b) reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and (c) exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, our stockholders may not have access to certain information they may deem important. We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year in which the market value of shares of common stock that are held by non-affiliates exceeds $700 million as of March 30 of that fiscal year, (ii) the last day of the fiscal year in which it has total annual gross revenue of $1.235 billion or more during such fiscal year (as indexed for inflation), (iii) the date on which it has issued more than $1 billion in non-convertible debt in the prior three-year period or (iv) December 31, 2026, which is the last day of the fiscal year following the fifth anniversary of the date of the first sale of common stock in CLIN's IPO. We cannot predict whether investors will find our securities less attractive because it will rely on these exemptions. If some investors find our securities less attractive as a result of its reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. As an emerging growth company, we may also take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to obtain an assessment of the effectiveness of our internal controls over financial reporting from our independent registered public accounting firm pursuant to Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. We cannot predict if investors will find our shares of common stock less attractive because we will rely on these exemptions. If some investors find our shares of common stock less attractive as a result, there may be a less active market for our shares of common stock and our share price may be more volatile. Additionally, we qualify as a "smaller reporting company" as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We expect that we will remain a smaller reporting company until the last day of any fiscal year for so long as either (a) the market value of our common stock held by non-affiliates does not equal or exceed $250 million as of the end of that year's second quarter, or (b) our annual revenues did not equal or exceed $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates did not equal or exceed $700 million as of the end of that year's second quarter. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible. Our common stock is quoted on the OTC Market and we may be unable to list our securities on a national securities exchange, which limits liquidity and may adversely affect the trading price of our common stock and our ability to raise capital. Our common stock is currently quoted on the OTC Market following our delisting from The Nasdaq Capital Market in February 2025.  We may seek to list our common stock on a national securities exchange, such as Nasdaq or the NYSE, in the future; however, there can be no assurance that we will meet or maintain the applicable listing standards, or that any application we may submit will be approved. National securities exchanges impose quantitative and qualitative requirements for listing, including minimum bid price, market value of listed securities, minimum stockholders' equity or net income thresholds, corporate governance requirements, and minimum numbers of round lot holders, among other criteria.  Given our current market capitalization, stock price, financial condition, and the material weaknesses in our internal control over financial reporting, we may not be able to satisfy these requirements in the near term, if at all. The failure to obtain or maintain a listing on a national securities exchange could have material adverse consequences, including: - a limited availability of market quotations for our securities and reduced visibility to investors and analysts;- reduced liquidity and wider bid-ask spreads for our securities, making it more difficult for stockholders to sell their shares at prices they consider acceptable;- a limited amount of news, research, and analyst coverage for the Company, which may reduce institutional investor interest in our securities;- a decreased ability to issue additional securities, attract strategic partners, or obtain financing on favorable terms, as certain institutional investors are prohibited from or are reluctant to invest in securities that are not listed on a national exchange;- potential negative perception among customers, suppliers, partners, and employees, which could harm our ability to execute our business strategy;- the inability to use short-form registration statements on Forms S-3 or S-8 for certain offerings if we fail to meet applicable eligibility requirements, which would increase the cost and complexity of future capital raises; and - certain contractual rights of our security holders, including conversion triggers and escrow release conditions in our preferred stock designations and note purchase agreements, may not be satisfied if an uplisting does not occur within specified timeframes, which could result in adverse financial consequences or disputes with counterparties. There can be no assurance that we will be able to list our securities on a national securities exchange. Even if we are able to list our securities, there can be no assurance that we will be able to maintain compliance with the continued listing requirements of such exchange. Our prior delisting from Nasdaq and our history of non-compliance with listing standards may make it more difficult for us to obtain approval for a future listing application.